Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial

Ketty Peris, R Saraceno, L Andreassi, F Ayala, Mr Bongiorno, A Giannetti, P Lisi, P Martini, A Peserico, S. Chimenti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

36 Citazioni (Scopus)

Abstract

A clinical trial was performed to evaluate the efficacy, speed of response, side effects and quality of life of patients treated with calcipotriol/betamethasone dipropionate (Dovobet) for 4 weeks followed by maintenance with calcipotriol for 8 weeks (group A) versus calcipotriol (Daivonex) alone for 12 weeks (group B) for the treatment of psoriasis.
Lingua originaleEnglish
pagine (da-a)361-365
Numero di pagine5
RivistaTHE JOURNAL OF DERMATOLOGICAL TREATMENT
Volume18
DOI
Stato di pubblicazionePubblicato - 2007

Keywords

  • Administration, Cutaneous
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Betamethasone
  • Calcitriol
  • Dermatologic Agents
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psoriasis
  • Quality of Life
  • Severity of Illness Index
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial'. Insieme formano una fingerprint unica.

Cita questo